![Anticoagulation Monitoring Part 2: Unfractionated Heparin and Low-Molecular-Weight Heparin | Semantic Scholar Anticoagulation Monitoring Part 2: Unfractionated Heparin and Low-Molecular-Weight Heparin | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c52e0b965c9038f06f9f0c0417e73da157e7579d/7-Table3-1.png)
Anticoagulation Monitoring Part 2: Unfractionated Heparin and Low-Molecular-Weight Heparin | Semantic Scholar
![JCM | Free Full-Text | Running after Activated Clotting Time Values in Patients Receiving Direct Oral Anticoagulants: A Potentially Dangerous Race. Results from a Prospective Study in Atrial Fibrillation Catheter Ablation Procedures JCM | Free Full-Text | Running after Activated Clotting Time Values in Patients Receiving Direct Oral Anticoagulants: A Potentially Dangerous Race. Results from a Prospective Study in Atrial Fibrillation Catheter Ablation Procedures](https://www.mdpi.com/jcm/jcm-10-04240/article_deploy/html/images/jcm-10-04240-g001.png)
JCM | Free Full-Text | Running after Activated Clotting Time Values in Patients Receiving Direct Oral Anticoagulants: A Potentially Dangerous Race. Results from a Prospective Study in Atrial Fibrillation Catheter Ablation Procedures
![Activated Clotting Time Versus Activated Partial Thromboplastin Time for Therapeutic Monitoring of Heparin | Semantic Scholar Activated Clotting Time Versus Activated Partial Thromboplastin Time for Therapeutic Monitoring of Heparin | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9b0d925f3fd09d9064212c8db86a28600844337d/3-Table2-1.png)
Activated Clotting Time Versus Activated Partial Thromboplastin Time for Therapeutic Monitoring of Heparin | Semantic Scholar
Activated Clotting Time (ACT) for Monitoring of Low-Dose Heparin: Performance Characteristics in Healthy Adults and Critically I
![JCM | Free Full-Text | Monitoring of Unfractionated Heparin Therapy in the Intensive Care Unit Using a Point-of-Care aPTT: A Comparative, Longitudinal Observational Study with Laboratory-Based aPTT and Anti-Xa Activity Measurement JCM | Free Full-Text | Monitoring of Unfractionated Heparin Therapy in the Intensive Care Unit Using a Point-of-Care aPTT: A Comparative, Longitudinal Observational Study with Laboratory-Based aPTT and Anti-Xa Activity Measurement](https://pub.mdpi-res.com/jcm/jcm-11-01338/article_deploy/html/images/jcm-11-01338-g001-550.jpg?1646286004)
JCM | Free Full-Text | Monitoring of Unfractionated Heparin Therapy in the Intensive Care Unit Using a Point-of-Care aPTT: A Comparative, Longitudinal Observational Study with Laboratory-Based aPTT and Anti-Xa Activity Measurement
![Usefulness of Baseline Activated Clotting Time–Guided Heparin Administration in Reducing Bleeding Events During Transfemoral Transcatheter Aortic Valve Implantation - ScienceDirect Usefulness of Baseline Activated Clotting Time–Guided Heparin Administration in Reducing Bleeding Events During Transfemoral Transcatheter Aortic Valve Implantation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1936879813017020-gr1.jpg)
Usefulness of Baseline Activated Clotting Time–Guided Heparin Administration in Reducing Bleeding Events During Transfemoral Transcatheter Aortic Valve Implantation - ScienceDirect
![Diagnostics | Free Full-Text | Laboratory Assessment of Unfractionated Heparin (UFH) with Activated Clotting Time (ACT) and Anti-Xa Activity during Peripheral Arterial Angiographic Procedure Diagnostics | Free Full-Text | Laboratory Assessment of Unfractionated Heparin (UFH) with Activated Clotting Time (ACT) and Anti-Xa Activity during Peripheral Arterial Angiographic Procedure](https://www.mdpi.com/diagnostics/diagnostics-13-01489/article_deploy/html/images/diagnostics-13-01489-g001.png)
Diagnostics | Free Full-Text | Laboratory Assessment of Unfractionated Heparin (UFH) with Activated Clotting Time (ACT) and Anti-Xa Activity during Peripheral Arterial Angiographic Procedure
![Limitations of activated clotting time (ACT) in heparin monitoring with... | Download Scientific Diagram Limitations of activated clotting time (ACT) in heparin monitoring with... | Download Scientific Diagram](https://www.researchgate.net/publication/12780041/figure/fig4/AS:341459313152008@1458421652680/Limitations-of-activated-clotting-time-ACT-in-heparin-monitoring-with-cardiopulmonary.png)
Limitations of activated clotting time (ACT) in heparin monitoring with... | Download Scientific Diagram
![Anticoagulation Monitoring Part 2: Unfractionated Heparin and Low-Molecular-Weight Heparin | Semantic Scholar Anticoagulation Monitoring Part 2: Unfractionated Heparin and Low-Molecular-Weight Heparin | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c52e0b965c9038f06f9f0c0417e73da157e7579d/3-Table1-1.png)
Anticoagulation Monitoring Part 2: Unfractionated Heparin and Low-Molecular-Weight Heparin | Semantic Scholar
![Correlation between Activated Clotting Time and Activated Partial Thromboplastin Times | Semantic Scholar Correlation between Activated Clotting Time and Activated Partial Thromboplastin Times | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/8b07b294e1bfb0da322b99591ada974b3b45b507/2-Table1-1.png)